Capital Research Global Investors Ideaya Biosciences, Inc. Transaction History
Capital Research Global Investors
- $443 Billion
- Q2 2024
A detailed history of Capital Research Global Investors transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 2,164,551 shares of IDYA stock, worth $66.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,164,551
Previous 1,976,870
9.49%
Holding current value
$66.7 Million
Previous $86.7 Million
12.39%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding IDYA
# of Institutions
206Shares Held
73.6MCall Options Held
21.5KPut Options Held
20.3K-
Black Rock Inc. New York, NY6.81MShares$210 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$150 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.27MShares$131 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.08MShares$126 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.74MShares$115 Million0.02% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.48B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...